Physician profile
Peter D Roman
NPI 1922072495
$3,735.23
in general payments reported to CMS, 2019-2025
27 companies · $727 in 2025
The $727 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,500 · 2020: $186 · 2021: $71.55 · 2022: $289 · 2023: $435 · 2024: $527 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,689.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,016.66 | 2019-2025 | T2 Alpha, Mako, Augment Injectable |
| Medical Device Business Services, INC. | $790.00 | 2019 | |
| Smith+Nephew, INC. | $412.51 | 2019-2025 | Pico |
| Heron Therapeutics, INC. | $269.08 | 2022-2025 | Zynrelef |
| Acumed LLC | $211.25 | 2019-2025 | Acumed, Acumed |
| Radius Health, INC. | $193.54 | 2019-2025 | |
| Vertex Pharmaceuticals Incorporated | $157.19 | 2024-2025 | |
| Kairos Surgical INC | $82.59 | 2023 | |
| Polynovo North America LLC | $70.26 | 2023-2025 | Novosorb Btm |
| Organogenesis INC. | $65.60 | 2025 | Puraply Wound Matrix |
| Bioventus LLC | $59.08 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $55.75 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $43.34 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $41.28 | 2019-2024 | Iovera, Zilretta, Exparel |
| Depuy Synthes Sales INC. | $30.71 | 2024 | Orthovisc, Monovisc |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $28.80 | 2025 | Evenity |
| Convatec INC. | $27.21 | 2024 | |
| Sanara Medtech INC. | $22.23 | 2024 | Celleraterx |
| Medtronic USA, INC. | $22.00 | 2019 | |
| Djo, LLC | $21.97 | 2019 | |
| Endo USA, INC. | $18.98 | 2024 | Xiaflex |
| Baudax Bio INC. | $17.95 | 2021 | |
| Heraeus Medical, LLC. | $17.20 | 2019 | |
| Orthofix Medical, INC. | $16.51 | 2023 | Physio-Stim |
| Sanofi-Aventis U.S. LLC | $15.72 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.27 | 2022 | |
| Wright Medical Technology, INC. | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Roman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.